Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
Cross-reactivity
Viruses with RNA Genomes
Antimicrobial Proteins
Arboviral Encephalitis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 18, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
1Institute of Virology, Hannover Medical School, Hannover, Germany. kuehl.annika@mh-hannover.de
Ebola virus (EBOV) evades the human interferon (IFN) system, hindering innate immunity. Understanding how EBOV fights IFN-inducible proteins like IFITMs and tetherin is crucial for developing antiviral therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: